- Economy
- Education And Career
- Companies & Markets
- Gadgets & Technology
- After Hours
- Healthcare
- Banking & Finance
- Entrepreneurship
- Energy & Infra
- Case Study
- Video
- More
- Sustainability
- Web Exclusive
- Opinion
- Luxury
- Legal
- Property Review
- Cloud
- Blockchain
- Workplace
- Collaboration
- Developer
- Digital India
- Infrastructure
- Work Life Balance
- Test category by sumit
- Sports
- National
- World
- Entertainment
- Lifestyle
- Science
- Health
- Tech
Latest Articles in glenmark pharmaceuticals
Glenmark Pharmaceuticals receives ANDA tentative approval for Dabigatran Etexilate Capsules, 75 mg, 110 mg, and 150 mg
Glenmark Pharmaceuticals receives ANDA tentative approval for Dabigatran Etexilate Capsules, 75 mg, 110 mg, and 150 mg
Read MoreRecently published data on Favipiravir as treatment for mild to moderate COVID-19 demonstrates significant improvement in time to clinical cure
Recently published data on Favipiravir as treatment for mild to moderate COVID-19 demonstrates significant improvement in time to clinical cure
Read MoreGlenmark Pharmaceuticals receives ANDA approval for Tacrolimus Capsules USP, 0.5 mg, 1 mg and 5 mg
Glenmark Pharmaceuticals receives ANDA approval for Tacrolimus Capsules USP, 0.5 mg, 1 mg and 5 mg
Read MoreGlenmark Pharmaceuticals receives ANDA approval for Sirolimus tablets, 0.5 mg, 1 mg and 2 mg
Glenmark Pharmaceuticals receives ANDA approval for Sirolimus tablets, 0.5 mg, 1 mg and 2 mg
Read MoreGlenmark introduces NINDANIB (Nintedanib) and is amongst the first to launch the branded generic version at an affordable cost for the treatment of Pulmonary Fibrosis in India
Glenmark introduces NINDANIB (Nintedanib) and is amongst the first to launch the branded generic version at an affordable cost for the treatment of Pulmonary Fibrosis in India
Read MoreGlenmark Pharmaceuticals receives ANDA approval for Dimethyl Fumarate Delayed-Release Capsules, 120 mg and 240 mg
Glenmark Pharmaceuticals receives ANDA approval for Dimethyl Fumarate Delayed-Release Capsules, 120 mg and 240 mg
Read MoreGlenmark appoints Dipankar Bhattacharjee to its Board of Directors
Glenmark appoints Dipankar Bhattacharjee to its Board of Directors
Read More
Glenmark Introduces Higher Strength Of Fabiflu To Reduce Pill Burden Of Covid-19 Treatment
The higher strength will improve patient compliance and experience by effectively reducing the number of tablets that patients require per day
Read More
Glenmark Cuts COVID-19 Drug Favipiravir Price By 27 %
"Our priority from the start of this pandemic has been to offer patients in India an effective treatment for COVID-19 while also ensuring accessibility to the masses,"
Read MoreFitch affirms Glenmark Pharmaceuticals at BB, withdraws proposed bond rating
Fitch affirms Glenmark Pharmaceuticals at BB, withdraws proposed bond rating
Read More
Hindustan Unilever Completes Acquisition Of VWash From Glenmark Pharma
HUL has acquired intellectual property rights including trademarks, design and know-how related to the VWash brand worldwide.
Read More
Sensex Closes 180 Points Up, Glenmark Pharma Jumps 27 Pc
Cipla's stock jumped by 2.9 per cent to Rs 655.80 per unit after it announced the launch of remdesivir under its brand name Cipremi.
Read More
Glenmark, Cipla Stocks Surge After Nod To Launch Drugs For Mild-to-moderate COVID-19 Infections
At the same time, Cipla's stock jumped by 4.3 per cent to Rs 664.45 per unit after it announced the launch of remdesivir under its brand name Cipremi.
Read More
Glenmark Pharmaceuticals Gets USFDA Nod For Fingolimod Capsules
Shares of Glenmark Pharmaceuticals were trading at Rs 411.20 a piece on BSE in morning trade, up 1.44 per cent from their previous close.
Read More